Trial Profile
A comparison of Dysport (100 U/ml) and Botox (100 U/ml) using dose conversion factor 3:1 and 1.7:1 in the treatment of cervical dystonia.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 21 Sep 2015
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Torticollis
- Focus Therapeutic Use
- Acronyms DysBot
- 11 Sep 2015 Results published in the Clinical Neuropharmacology.
- 12 Jul 2011 New trial record